The new FDA reality.
Citation: Cardiovascular Revascularization Medicine. 15(1):1-2, 2014 Jan.PMID: 24444470Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): EditorialSubject headings: *Clinical Trials as Topic/mt [Methods] | *Device Approval | *Research Design | *United States Food and Drug Administration | Clinical Trials as Topic/lj [Legislation & Jurisprudence] | Device Approval/lj [Legislation & Jurisprudence] | Evidence-Based Medicine | Health Policy | Humans | Patient Safety | Research Design/lj [Legislation & Jurisprudence] | Risk Assessment | Risk Factors | Time Factors | United States | United States Food and Drug Administration/lj [Legislation & Jurisprudence]Year: 2014Local holdings: Available in print through MWHC library: 2002 - presentISSN:- 1878-0938
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 24444470 | Available | 24444470 |
Available in print through MWHC library: 2002 - present
English